[Periodontal disease, a risk factor for atherosclerotic cardiovascular disease]

Dorottya Gheorghita1, Gabriella Eördegh1, Ferenc Nagy2

  • 1Konzerváló és Esztétikai Fogászati Tanszék, Szegedi Tudományegyetem, Fogorvostudományi Kar Szeged, Tisza Lajos körút 64-66., 6720.

Orvosi Hetilap
|March 12, 2019
PubMed

Insights

Periodontal disease may increase cardiovascular disease risk by promoting systemic inflammation and atherosclerosis. Maintaining oral health and treating periodontitis could help reduce this risk.

Area of Science:

  • Cardiovascular Medicine
  • Periodontology
  • Inflammation Research

Background:

  • Cardiovascular disease is the leading global cause of death, often linked to atherosclerosis and thromboembolic events.
  • Inflammation plays a critical role in the development of atherosclerosis and atherothrombosis.
  • Emerging evidence suggests a link between periodontal disease (periodontitis) and increased risk of cardiovascular disease.

Purpose of the Study:

  • To review the pathophysiological mechanisms connecting periodontal disease and cardiovascular pathology.
  • To summarize clinical evidence linking periodontitis to specific cardiovascular diseases.
  • To explore the potential of periodontal treatment in cardiovascular disease prevention and management.

Main Methods:

  • Literature review of studies investigating the relationship between periodontal disease and cardiovascular disease.
  • Analysis of pathophysiological pathways involving microbial and inflammatory processes.
  • Synthesis of clinical evidence and epidemiological data.

Main Results:

  • Chronic periodontitis can act as a reservoir for pathogens, increasing systemic inflammation.
  • Oral bacteria and their products entering circulation can exacerbate atherosclerosis progression.
  • Clinical studies show an association between periodontitis and increased risk of cardiovascular events.

Conclusions:

  • Periodontal disease is a potential risk factor for atherosclerosis and cardiovascular disease.
  • Good oral hygiene and periodontal treatment may contribute to cardiovascular risk reduction.
  • Further research is warranted to fully elucidate the role of periodontal interventions in cardiovascular health.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
464
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.4K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.4K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.2K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.0K